NASDAQ, REGN - Regeneron Pharmaceuticals
This Annual Report on Form 10-K contains forward-looking statements that involve
risks and uncertainties relating to future events and the future financial
performance of Regeneron Pharmaceuticals, Inc., and actual events or results may
differ materially. These statements concern, among other things, the possible
success and therapeutic applications of our product candidates and research
programs, the timing and nature of the clinical and research programs now
underway or planned, and the future sources and uses of capital and our
financial needs. These statements are made by us based on management?s current
beliefs and judgment. In evaluating such statements, stockholders and potential
investors should specifically consider the various factors identified under the
caption ?Risk Factors? which could cause actual results to differ materially
from those indicated by such forward-looking statements. ...
Read SEC Filing on NASDAQ.com »